The $100 billion opportunity: How anti-obesity drugs are reshaping healthcare and consumer behavior
Goldman Sachs Exchanges
00:00
Analyzing the Market Potential and Manufacturing Challenges of Anti-Obesity Drugs
Exploring the current market price of anti-obesity drugs, the government's decision on Medicare coverage, and the challenges in manufacturing and supply.
Transcript
Play full episode
